# Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

> **NCT00005827** · PHASE1 · WITHDRAWN · sponsor: **UNC Lineberger Comprehensive Cancer Center**

## Conditions studied

- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** genistein

## Key facts

- **NCT ID:** NCT00005827
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 1999-12
- **Primary completion:** 2003-05
- **Final completion:** 2003-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005827, "Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00005827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*